INTERLEUKIN-10 INDUCES B-LYMPHOCYTES FROM IGA-DEFICIENT PATIENTS TO SECRETE IGA

被引:120
作者
BRIERE, F
BRIDON, JM
CHEVET, D
SOUILLET, G
BIENVENU, F
GURET, C
MARTINEZVALDEZ, H
BANCHEREAU, J
机构
[1] HOP BOCAGE, UNITE NEPHROL & REANIMAT METAB, F-21034 DIJON, FRANCE
[2] HOP DEBROUSSE, F-69005 LYON, FRANCE
关键词
IGA DEFICIENCY; INTERLEUKIN-10; B LYMPHOCYTES; CD40; TRIGGERING; DIFFERENTIATION;
D O I
10.1172/JCI117354
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We have previously shown that human B lymphocytes cultured in the CD40 system, composed of an anti-CD40 mAb presented by a CD32-transfected fibroblastic cell line, proliferate hut do not secrete antibodies. However, the addition of particles of Staphylococcus aureus Cowan (SAC) induces B cell differentiation even in the absence of exogeneous cytokines (CD40/SAC system). Additionally, B lymphocytes cultured in the CD40 system in the presence of human IL-10, produce IgM, IgG, and IgA, and Tg levels are further increased by SAC. Here, we have studied the capacity of peripheral blood lymphocytes from patients with IgA deficiency (IgA-D) to secrete Igs, particularly IgA after CD40 triggering. Peripheral blood mononuclear cells (PBMNC) from IgA-D patients cultured in the CD40/SAC system produced IgM and IgG, but not IgA. The addition of IL-10 to the cultures, enhanced the production of IgM and IgG and most strikingly induced the production of high amounts of IgA. The addition of IL-10 to PBMNC from IgA-D patients activated through CD40 alone resulted in the production of IgA. Thus, SAC and anti-CD40 mAb stimulate B cells to differentiate into cells secreting IgG and IgM whereas IL-10 plays a central role in inducing B cells from IgA-D patients to differentiate into IgA secreting cells.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 38 条
[11]   INTERFERON-GAMMA INHIBITS INTERLEUKIN-10 PRODUCTION BY MONOCYTES [J].
CHOMARAT, P ;
RISSOAN, MC ;
BANCHEREAU, J ;
MIOSSEC, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :523-527
[12]   REGULATION OF HUMAN IGE SYNTHESIS .1. HUMAN IGE SYNTHESIS INVITRO IS DETERMINED BY THE RECIPROCAL ANTAGONISTIC EFFECTS OF INTERLEUKIN-4 AND INTERFERON-GAMMA [J].
CHRETIEN, I ;
PENE, J ;
BRIERE, F ;
MALEFIJT, RD ;
ROUSSET, F ;
DEVRIES, JE .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (02) :243-251
[13]   IMMATURE IGA B-CELLS IN IGA-DEFICIENT PATIENTS [J].
CONLEY, ME ;
COOPER, MD .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (09) :495-497
[14]   INTERLEUKIN-10 AND TRANSFORMING GROWTH-FACTOR-BETA COOPERATE TO INDUCE ANTI-CD40 ACTIVATED NAIVE HUMAN B-CELLS TO SECRETE IMMUNOGLOBULIN-A [J].
DEFRANCE, T ;
VANBERVLIET, B ;
BRIERE, F ;
DURAND, I ;
ROUSSET, F ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) :671-682
[15]  
DEFRANCE T, 1987, J IMMUNOL, V139, P1135
[16]   CD40 LIGAND MUTATIONS IN X-LINKED IMMUNODEFICIENCY WITH HYPER-IGM [J].
DISANTO, JP ;
BONNEFOY, JY ;
GAUCHAT, JF ;
FISCHER, A ;
DESAINTBASILE, G .
NATURE, 1993, 361 (6412) :541-543
[17]   EPITOPE MAPPING OF RECOMBINANT HUMAN GAMMA-INTERFERON USING MONOCLONAL-ANTIBODIES [J].
FAVRE, C ;
WIJDENES, J ;
CABRILLAT, H ;
DJOSSOU, O ;
BANCHEREAU, J ;
DEVRIES, JE .
MOLECULAR IMMUNOLOGY, 1989, 26 (01) :17-25
[18]   ANTIBODIES TO CACHECTIN TUMOR NECROSIS FACTOR REDUCE INTERLEUKIN-1-BETA AND INTERLEUKIN-6 APPEARANCE DURING LETHAL BACTEREMIA [J].
FONG, YM ;
TRACEY, KJ ;
MOLDAWER, LL ;
HESSE, DG ;
MANOGUE, KB ;
KENNEY, JS ;
LEE, AT ;
KUO, GC ;
ALLISON, AC ;
LOWRY, SF ;
CERAMI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05) :1627-1633
[19]   SELECTIVE IGA DEFICIENCY - ANALYSIS OF IG PRODUCTION INVITRO [J].
INOUE, T ;
OKUBO, H ;
KUDO, J ;
IKUTA, T ;
HACHIMINE, K ;
SHIBATA, R ;
YOSHINARI, O ;
FUKADA, K ;
YANASE, T .
JOURNAL OF CLINICAL IMMUNOLOGY, 1984, 4 (03) :235-241
[20]   MODIFIED IMMUNOLOGICAL STATUS OF ANTI-IL-10 TREATED MICE [J].
ISHIDA, H ;
HASTINGS, R ;
THOMPSONSNIPES, L ;
HOWARD, M .
CELLULAR IMMUNOLOGY, 1993, 148 (02) :371-384